1,252
Participants
Start Date
October 15, 2007
Primary Completion Date
December 21, 2007
Study Completion Date
June 4, 2008
Fluarix
Single dose, Intramuscular injection
GSK Biologicals Influenza Vaccine GSK576389A
Single dose, Intramuscular injection
GSK Investigational Site, Bekkestua
GSK Investigational Site, Hamar
GSK Investigational Site, Elverum
GSK Investigational Site, Skien
GSK Investigational Site, Bergen
GSK Investigational Site, Haugesund
GSK Investigational Site, Ghent
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Poughkeepsie
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Carnegie
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Rüdersdorf
GSK Investigational Site, Erie
GSK Investigational Site, Coral Gables
GSK Investigational Site, Clearwater
GSK Investigational Site, Chaska
GSK Investigational Site, Haag
GSK Investigational Site, Langquaid
GSK Investigational Site, Höhenkirchen-Siegertsbrunn
GSK Investigational Site, Augsburg
GSK Investigational Site, Messkirch
GSK Investigational Site, Milford
GSK Investigational Site, Somers Point
GSK Investigational Site, Leipzig
GSK Investigational Site, Fredrikstad
Lead Sponsor
GlaxoSmithKline
INDUSTRY